Startup News Today: HealthTech Firm Gabify Secures $175,000 for AI Diagnosis Tools

Reducing diagnosis times for childhood neurodevelopmental disorders by up to 70% could be a game-changer in healthcare. Gabify's innovative AI platform is stepping into this space with a fresh approach, blending voice analysis, facial recognition, and behavioral tracking to spot issues like autism or ADHD early on. Founded just last year, the startup has already snagged $175,000 in pre-seed funding, led by Inflection Point Ventures, plus support from India's Nidhi Seed Support Scheme.

In my experience coaching entrepreneurs, what stands out here is their human-in-the-loop model – AI does the heavy lifting on screening across 189 validated parameters, but clinicians double-check for accuracy. This isn't just tech for tech's sake; it's designed to ease the burden on overburdened specialists and get kids the interventions they need faster. They've tested it in over 35 preschools during beta, proving it can scale while keeping standards high.

"Our goal is to ensure no child is left behind due to delayed diagnosis," shares CEO Sahil Chopra, and I couldn't agree more – especially with a $110 billion global market waiting. As they eye B2B, B2C, and CSR paths to reach a million kids by 2028, this feels like a smart bet on AI's role in bridging care gaps. Check out the full article to explore how Gabify is redefining early detection.